Registro:

Referencias:

• Docampo, R., Moreno, S.N.J., The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites (2008) Current Pharmaceutical Design, 14 (9), pp. 882-888. , http://www.ingentaconnect.com/content/ben/cpd/2008/00000014/00000009/ art00007, DOI 10.2174/138161208784041079
• Urbina, J.A., Docampo, R., Specific chemotherapy of Chagas disease: Controversies and advances (2003) Trends in Parasitology, 19 (11), pp. 495-501. , DOI 10.1016/j.pt.2003.09.001
• http://www.who.int/topics/tropical_diseases/en/; Brener, Z., Biology of Trypanosoma cruzi (1973) Annu. Rev. Microbiol., 27, pp. 347-382
• Kirchhoff, L.V., Epidemiology of American trypanosomiasis (Chagas disease) (2011) Adv. Parasitol., 75, pp. 1-18
• Kirchhoff, L.V., Current concepts: American trypanosomiasis (Chagas' disease) - A tropical disease now in the United States (1993) New England Journal of Medicine, 329 (9), pp. 639-644. , DOI 10.1056/NEJM199308263290909
• Moreno, S.N.J., Li, Z.-H., Targeting the isoprenoid pathway of Toxoplasma gondii (2008) Expert Opinion on Therapeutic Targets, 12 (3), pp. 253-263. , DOI 10.1517/14728222.12.3.253
• Rodriguez, J.B., Szajnman, S.H., New antibacterials for the treatment of toxoplasmosis; A patent review (2012) Expert Opin. Ther. Pat., 22, pp. 311-334
• Dubey, J.P., Lindsay, D.S., Speer, C.A., Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts (1998) Clinical Microbiology Reviews, 11 (2), pp. 267-299
• Urbina, J.A., Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches (2010) Acta Trop., 115, pp. 55-68
• Urbina, J.A., New insights in Chagas disease treatment (2010) Drugs Fut., 35, pp. 409-420
• Urbina, J.A., Parasitological Cure of Chagas Disease: Is it Possible? Is it Relevant? (1999) Memorias do Instituto Oswaldo Cruz, 94 (SUPPL. 1), pp. 349-355
• Docampo, R., Moreno, S.N., Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites (2001) Curr. Drug Targets Infect. Disord., 1, pp. 51-61
• Gelb, M.H., Van Voorhis, W.C., Buckner, F.S., Yokoyama, K., Eastman, R., Carpenter, E.P., Panethymitaki, C., Smith, D.F., Protein farnesyl and N-myristoyl transferases: Piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics (2003) Molecular and Biochemical Parasitology, 126 (2), pp. 155-163. , DOI 10.1016/S0166-6851(02)00282-7, PII S0166685102002827
• Eberl, M., Hintz, M., Reichenberg, A., Kollas, A.-K., Wiesner, J., Jomaa, H., Microbial isoprenoid biosynthesis and human γδ T cell activation (2003) FEBS Letters, 544 (1-3), pp. 4-10. , DOI 10.1016/S0014-5793(03)00483-6
• Banthorpe, D.V., Charlwood, B.V., Francis, M.J., The biosynthesis of monoterpenes (1972) Chem. Rev., 72, pp. 115-155
• Nair, S.C., Brooks, C.F., Goodman, C.D., Sturm, A., McFadden, G.I., Sundriyal, S., Anglin, J.L., Striepen, B., Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii (2011) J. Exp. Med., 208, pp. 1547-1559
• Urbina, J.A., Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites (1997) Parasitology, 117, pp. 91-S99
• Urbina, J.A., Specific treatment of Chagas disease: Current status and new developments (2001) Current Opinion in Infectious Diseases, 14 (6), pp. 733-741
• Urbina, J.A., Chemotherapy of Chagas disease (2002) Current Pharmaceutical Design, 8 (4), pp. 287-295. , DOI 10.2174/1381612023396177
• Elhalem, E., Bailey, B.N., Docampo, R., Ujvary, I., Szajnman, S.H., Rodriguez, J.B., Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi (2002) Journal of Medicinal Chemistry, 45 (18), pp. 3984-3999. , DOI 10.1021/jm0201518
• Szajnman, S.H., Yan, W., Bailey, B.N., Docampo, R., Elhalem, E., Rodriguez, J.B., Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation (2000) Journal of Medicinal Chemistry, 43 (9), pp. 1826-1840. , DOI 10.1021/jm9905007
• Cinque, G.M., Szajnman, S.H., Zhong, L., Docampo, R., Schvartzapel, A.J., Rodriguez, J.B., Gros, E.G., Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi (1998) Journal of Medicinal Chemistry, 41 (9), pp. 1540-1554. , DOI 10.1021/jm970860z
• Urbina, J.A., Concepcion, J.L., Montalvetti, A., Rodriguez, J.B., Docampo, R., Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas' disease (2003) Antimicrobial Agents and Chemotherapy, 47 (6), pp. 2047-2050. , DOI 10.1128/AAC.47.6.2047-2050.2003
• Concepcion, J.L., Gonzalez-Pacanowska, D., Urbina, J.A., 3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: Subcellular localization and kinetic properties (1998) Archives of Biochemistry and Biophysics, 352 (1), pp. 114-120. , DOI 10.1006/abbi.1998.0577
• Blagg, B.S.J., Jarstfer, M.B., Rogers, D.H., Poulter, C.D., Recombinant squalene synthase. A mechanism for the rearrangement of presqualene diphosphate to squalene (2002) Journal of the American Chemical Society, 124 (30), pp. 8846-8853. , DOI 10.1021/ja020411a
• Jarstfer, M.B., Zhang, D.-L., Poulter, C.D., Recombinant squalene synthase. Synthesis of non-head-to-tail isoprenoids in the absence of NADPH (2002) Journal of the American Chemical Society, 124 (30), pp. 8834-8845. , DOI 10.1021/ja020410i
• Brown, G.R., Clarke, D.S., Foubister, A.J., Freeman, S., Harrison, P.J., Johnson, M.C., Mallion, K.B., Taylor, M.J., Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors (1996) Journal of Medicinal Chemistry, 39 (15), pp. 2971-2979. , DOI 10.1021/jm950907l
• Ugawa, T., Kakuta, H., Moritani, H., Matsuda, K., Ishihara, T., Yamaguchi, M., Naganuma, S., Shikama, H., YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglycerides in several animal species (2000) Br. J. Pharmacol., 131, pp. 63-70
• Coppens, I., Sinai, A.P., Joiner, K.A., Toxoplasma gondii exploits host low-density lipoprotein receptor- mediated endocytosis for cholesterol acquisition (2000) Journal of Cell Biology, 149 (1), pp. 167-180. , DOI 10.1083/jcb.149.1.167
• Schvartzapel, A.J., Zhong, L., Docampo, R., Rodriguez, J.B., Gros, E.G., Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes) (1997) Journal of Medicinal Chemistry, 40 (15), pp. 2314-2322. , DOI 10.1021/jm9607616
• Linares, G.G., Gismondi, S., Codesido, N.O., Moreno, S.N.J., Docampo, R., Rodriguez, J.B., Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation (2007) Bioorganic and Medicinal Chemistry Letters, 17 (18), pp. 5068-5071. , DOI 10.1016/j.bmcl.2007.07.012, PII S0960894X07008141
• García Liñares, G.E., Ravaschino, E.L., Rodriguez, J.B., Progresses in the field of drug design to combat tropical protozoan parasitic diseases (2006) Curr. Med. Chem., 13, pp. 335-360
• Evans, D.A., Katz, J.L., West, T.R., Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine (1998) Tetrahedron Letters, 39 (19), pp. 2937-2940. , DOI 10.1016/S0040-4039(98)00502-4, PII S0040403998005024
• Chan, D.M.T., Monaco, K.L., Wang, R.-P., Winters, M.P., New N- and O-arylations with phenylboronic acids and cupric acetate (1998) Tetrahedron Letters, 39 (19), pp. 2933-2936. , DOI 10.1016/S0040-4039(98)00503-6, PII S0040403998005036
• Maiti, D., Buchwald, S.L., Orthogonal Cu- and Pd-based catalyst systems for the O- and N-arylation of aminophenols (2009) J. Am. Chem. Soc., 131, pp. 17423-17429
• Bhayana, B., Fors, B.P., Buchwald, S.L., A versatile catalyst system for Suzuki-Miyaura cross-coupling reactions of C(sp2)-tosylates and mesylates (2009) Org. Lett., 11, pp. 3954-3957
• Fors, B.P., Watson, D.A., Biscoe, M.R., Buchwald, S.L., A highly active catalyst for Pd-catalyzed amination reactions: Cross-coupling reactions using aryl mesylates and the highly selective monoarylation of primary amines using aryl chlorides (2008) J. Am. Chem. Soc., 130, pp. 13552-13554
• Lin, F.-Y., Liu, Y.-L., Li, K., Cao, R., Zhu, W., Axelson, J., Pang, R., Oldfield, E., Head-to-head prenyl transferases: Anti-infective drug targets (2012) J. Med. Chem., 55, pp. 4367-4372
• Schvartzapel, A.J., Fichera, L., Esteva, M., Rodriguez, J.B., Gros, E.G., Design, synthesis and anti-Trypanosoma cruzi evaluation of a new class of cell growth inhibitors structurally related to fenoxycarb (1995) Helv. Chim. Acta, 78, pp. 1207-1214
• Grellier, P., Valentin, A., Millerioux, V., Schrevel, J., Rigomier, D., 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes (1994) Antimicrobial Agents and Chemotherapy, 38 (5), pp. 1144-1148
• Pradines, B., Torrentino-Madamet, M., Fontaine, A., Henry, M., Baret, E., Mosnier, J., Briolant, S., Rogier, C., Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum [3] (2007) Antimicrobial Agents and Chemotherapy, 51 (7), pp. 2654-2655. , DOI 10.1128/AAC.01330-06
• Bessoff, K., Sateriale, A., Lee, K.K., Huston, C.D., Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth (2013) Antimcrob. Agents Chemother., 57, pp. 1804-1814
• Cortez, E., Stumbo, A.C., Olieveira, M., Barbosa, H.S., Carvalho, L., Statins inhibit Toxoplasma gondii multiplication in macrophages in vitro (2009) Int. J. Antimcrob. Agents, 33, pp. 185-186
• Canavaci, A.M., Bustamante, J.M., Padilla, A.M., Pereza Brandan, C.M., Simpson, L.J., Xu, D., Boehlke, C.L., Tarleton, R.L., In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds (2010) PLOS Negl. Trop. Dis., 4, p. 740
• Gubbels, M.-J., Li, C., Striepen, B., High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein (2003) Antimicrobial Agents and Chemotherapy, 47 (1), pp. 309-316. , DOI 10.1128/AAC.47.1.309-316.2003
• Agrawal, S., Van Dooren, G.G., Beatty, W.L., Striepen, B., Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins (2009) J. Biol. Chem., 284, pp. 33683-33691
• Recher, M., Barboza, A.P., Li, Z.-H., Galizzi, M., Ferrer-Casal, M., Szajnman, S.H., Docampo, R., Rodriguez, J.B., Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents (2013) Eur. J. Med. Chem., 60, pp. 431-440

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------